Now showing items 1-8 of 8

    • Chiou, George C. (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2012-01-03)
      The present invention relates in general to therapeutic compositions and methods of use. In preferred embodiments, the invention relates to the field of eye health. In some embodiments, the invention relates to the prevention ...
    • Chiou, George C. (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2012-11-27)
      The present invention relates in general to therapeutic compositions and methods of use. In preferred embodiments, the invention relates to the field of eye health. In some embodiments, the invention relates to the prevention ...
    • Chiou, George C. Y. (United States. Patent and Trademark Office; Texas A&M University. Libraries, 1993-08-31)
      A novel compound for controlling (treatment and prevention) of ocular inflammation or systemic inflammatory disease is disclosed. The compound, OB-186, is effective at both the early and late phases of inflammation. The ...
    • Chiou, George C. Y. (United States. Patent and Trademark Office; Texas A&M University. Libraries, 1993-11-30)
      The invention relates to a method for increasing blood flow to the retina and choroid in subjects with decreased retinal or choroidal blood flow. The method involves the topical administration of droperidol and is useful ...
    • Chiou, George C. Y. (United States. Patent and Trademark Office; Texas A&M University. Libraries, 1993-10-12)
      The invention relates to a method for increasing blood flow to the retina and choroid in subjects with decreased retinal or choroidal blood flow. The method involves the topical administration of loxapine and is useful for ...
    • Chiou, George C. Y. (United States. Patent and Trademark Office; Texas A&M University. Libraries, 1994-09-06)
      A novel compound for the treatment and prevention of ocular and other types of inflammation is disclosed. The compound, OB-101, is effective at both the early and late phases of inflammation. The compound is useful for the ...
    • Chiou, George C. Y. (United States. Patent and Trademark Office; Texas A&M University. Libraries, 1993-03-16)
      A novel compound for the treatment and prevention of ocular inflammation is disclosed. The compound, OB-101, is effective at both the early and late phases of inflammation. The compound is useful for the treatment of ...
    • Chiou, George C. Y. (United States. Patent and Trademark Office; Texas A&M University. Libraries, 1993-03-30)
      A novel compound for the treatment and prevention of ocular inflammation is disclosed. The compound, OB-104, is effective at both the early and late phases of inflammation.